China · What does Hepalink invest in?
Hepalink invests most often at Series C (100% of the rounds on record), in sectors such as Biopharma, Biotechnology and Pharmaceutical.
Hepalink highlights
- 01
1 rounds on record
- 02
Mostly Series C: 100% of its rounds
What they do
- Type
- Corporate VC (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- BiopharmaBiotechnologyPharmaceutical
- Based in
- Shenzhen, China
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first1 appearances
- 2015
1 round
- Apr
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
What they claim to have backed
From their own portfolio page (on their website)
0 of 11 we have independently watched raise
BeianSPL天道医药中国天道医药德国天道医药意大利天道医药波兰天道医药美国天道医药英国天道医药西班牙社会招聘赛湾生物
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Companies it bought
Acquisitions by the firm itself
Cytovance Biologics$206MAug 2015
Scientific Protein Labs$337MJan 2014